Neuroinflammatory Role of Prostaglandins during Experimental Meningitis: Evidence Suggestive of an in Vivo Relationship between Nitric Oxide and Prostaglandins
- 1 January 2003
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 304 (1) , 319-325
- https://doi.org/10.1124/jpet.102.041533
Abstract
Nitric oxide (NO) and prostaglandins are inflammatory mediators produced during meningitis. The purpose of the present study was to pharmacologically inhibit cyclooxygenase-2 (COX-2) and inducible NO synthase (iNOS) to 1) explore the prostaglandin contribution to blood-cerebrospinal fluid barrier permeability alterations and 2) elucidate the in vivo concentration relationship between prostaglandin E2 (PGE2) and NO during experimental meningitis. Intracisternal injection of lipopolysaccharides (LPSs, 200 μg) induced neuroinflammation. Rats were dosed with nimesulide (COX-2 inhibitor), aminoguanidine (iNOS inhibitor), or vehicle. Evans blue was used to assess blood-cerebrospinal fluid barrier permeability. Meningeal NO and cerebrospinal fluid PGE2 were assayed using conventional methods. (Results are expressed as mean ± S.E.M. of 5–9 rats/group.) Nimesulide failed to prevent blood-cerebrospinal fluid barrier disruption [cerebrospinal fluid Evans blue (micrograms per milliliter): control, 0.22 ± 0.22*; LPS, 11.58 ± 0.66; LPS + nimesulide, 10.58 ± 0.86; *p < 0.05; ANOVA]. Although nimesulide decreased PGE2 (picograms per microliter; p < 0.01) in LPS + nimesulide rats (13.9 ± 1.96) versus LPS + vehicle (73.8 ± 12.4), meningeal NO production (picomoles/30 min/106 cells; p < 0.01) increased unexpectedly in LPS + nimesulide rats (439 ± 47) versus LPS + vehicle rats (211 ± 31). In contrast, aminoguanidine inhibited meningeal NO (picomoles/30 min/106 cells;p < 0.005) in LPS + aminoguanidine (111 ± 20) versus LPS (337 ± 48) but had no effects (p > 0.05) on PGE2. The in vivo relationship between PGE2 and NO was mathematically described by a biphasic, bell-shaped curve (r2 = 0.42; n = 27 rats; p < 0.0001). Based on these results, inhibition of prostaglandin synthesis not only fails to prevent blood-cerebrospinal fluid barrier disruption during neuroinflammation and but also promotes increased meningeal NO production. The in vivo concentration relationship between PGE2 and NO is biphasic, suggesting that inhibition of COX-2 alone may promote NO toxicity through enhanced NO synthesis.Keywords
This publication has 38 references indexed in Scilit:
- The Role of Glial Nitric Oxide in Neurotoxicity and Central Nervous System DiseasesPublished by Springer Nature ,1998
- Immunologic NO Synthase: Elevation in Severe AIDS Dementia and Induction by HIV-1 gp41Science, 1996
- Exacerbation of lymphocytic choriomeningitis in mice treated with the inducible nitric oxide synthase inhibitor aminoguanidineJournal of Neuroimmunology, 1996
- Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: A current appraisalNeurobiology of Aging, 1996
- Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitisBrain Research, 1996
- Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosisActa Neuropathologica, 1995
- Inhibition of nitric oxide synthase partially attenuates alterations in the blood-cerebrospinal fluid barrier during experimental meningitis in the ratEuropean Journal of Pharmacology, 1995
- Chapter 31 Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegenerationPublished by Elsevier ,1994
- IL-1.beta. induces the coexpression of both nitric oxide synthase and cyclooxygenase by Islets of Langerhans: activation of cyclooxygenase by nitric oxideBiochemistry, 1993
- Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell deathBrain Research, 1992